Stay updated on Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial

Sign up to get notified when there's something new on the Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    No Change Detected
  4. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.2%
    Check dated 2024-06-13T22:41:33.000Z thumbnail image
  5. Check
    4 days ago
    No Change Detected
  6. Check
    11 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the data related to the surveillance of adverse reactions and efficacy during long-term administration of Inovelon tablets in patients with Lennox-Gastaut Syndrome.
    Difference
    0.2%
    Check dated 2024-06-06T14:42:20.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage has been updated to include detailed eligibility criteria for participation in the study, specifying that all patients with Lennox-Gastaut syndrome who are administered Inovelon are eligible. It also now provides information on the age groups eligible for the study, which include children, adults, and older adults.
    Difference
    9%
    Check dated 2024-05-22T21:15:08.000Z thumbnail image
  8. Check
    47 days ago
    Change Detected
    Difference
    2%
    Check dated 2024-04-30T21:55:31.000Z thumbnail image

Stay in the know with updates to Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Long-term Safety of Inovelon in Lennox-Gastaut Syndrome Clinical Trial page.